Response to: Cardiac drugs and outcome in COVID-19
Gespeichert in:
Veröffentlicht in: | QJM : An International Journal of Medicine 2020-07, Vol.113 (7), p.525-526 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 526 |
---|---|
container_issue | 7 |
container_start_page | 525 |
container_title | QJM : An International Journal of Medicine |
container_volume | 113 |
creator | Goldstein, M R Poland, G A Graeber, C W |
description | |
doi_str_mv | 10.1093/qjmed/hcaa128 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2390145930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/qjmed/hcaa128</oup_id><sourcerecordid>2390145930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c349t-cfe902f965fa1a319d7d7eaa769bfbc3fd5164d54995a270bd6c8ea9325dde7e3</originalsourceid><addsrcrecordid>eNqFkDtPwzAURi0EoqUwsiKPLKF-xjEbSnlUqlQJAavl-AGpmji1k4F_T0tbMTLdT1dH39U9AFxjdIeRpNPNqnF2-mW0xqQ4AWPMcpQRKunpMQvCR-AipRVCiAlWnIMRJaSQWOAxIK8udaFNDvbhHpY62lobaOPwmaBuLQxDb0LjYN3Ccvkxn2VYXoIzr9fJXR3mBLw_Pb6VL9li-TwvHxaZoUz2mfFOIuJlzr3GmmJphRVOa5HLyleGestxzixnUnJNBKpsbgqnJSXcWiccnYDbfW8Xw2ZwqVdNnYxbr3XrwpDU9kmEGZcUbdFsj5oYUorOqy7WjY7fCiO106R-NamDpi1_c6geqt3-SB-9_N0OQ_dP1w8oAnEb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2390145930</pqid></control><display><type>article</type><title>Response to: Cardiac drugs and outcome in COVID-19</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Goldstein, M R ; Poland, G A ; Graeber, C W</creator><creatorcontrib>Goldstein, M R ; Poland, G A ; Graeber, C W</creatorcontrib><identifier>ISSN: 1460-2725</identifier><identifier>EISSN: 1460-2393</identifier><identifier>DOI: 10.1093/qjmed/hcaa128</identifier><identifier>PMID: 32289171</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Betacoronavirus ; Coronavirus Infections ; COVID-19 ; Humans ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2</subject><ispartof>QJM : An International Journal of Medicine, 2020-07, Vol.113 (7), p.525-526</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c349t-cfe902f965fa1a319d7d7eaa769bfbc3fd5164d54995a270bd6c8ea9325dde7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32289171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goldstein, M R</creatorcontrib><creatorcontrib>Poland, G A</creatorcontrib><creatorcontrib>Graeber, C W</creatorcontrib><title>Response to: Cardiac drugs and outcome in COVID-19</title><title>QJM : An International Journal of Medicine</title><addtitle>QJM</addtitle><subject>Betacoronavirus</subject><subject>Coronavirus Infections</subject><subject>COVID-19</subject><subject>Humans</subject><subject>Pandemics</subject><subject>Pneumonia, Viral</subject><subject>SARS-CoV-2</subject><issn>1460-2725</issn><issn>1460-2393</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDtPwzAURi0EoqUwsiKPLKF-xjEbSnlUqlQJAavl-AGpmji1k4F_T0tbMTLdT1dH39U9AFxjdIeRpNPNqnF2-mW0xqQ4AWPMcpQRKunpMQvCR-AipRVCiAlWnIMRJaSQWOAxIK8udaFNDvbhHpY62lobaOPwmaBuLQxDb0LjYN3Ccvkxn2VYXoIzr9fJXR3mBLw_Pb6VL9li-TwvHxaZoUz2mfFOIuJlzr3GmmJphRVOa5HLyleGestxzixnUnJNBKpsbgqnJSXcWiccnYDbfW8Xw2ZwqVdNnYxbr3XrwpDU9kmEGZcUbdFsj5oYUorOqy7WjY7fCiO106R-NamDpi1_c6geqt3-SB-9_N0OQ_dP1w8oAnEb</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Goldstein, M R</creator><creator>Poland, G A</creator><creator>Graeber, C W</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200701</creationdate><title>Response to: Cardiac drugs and outcome in COVID-19</title><author>Goldstein, M R ; Poland, G A ; Graeber, C W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c349t-cfe902f965fa1a319d7d7eaa769bfbc3fd5164d54995a270bd6c8ea9325dde7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Betacoronavirus</topic><topic>Coronavirus Infections</topic><topic>COVID-19</topic><topic>Humans</topic><topic>Pandemics</topic><topic>Pneumonia, Viral</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goldstein, M R</creatorcontrib><creatorcontrib>Poland, G A</creatorcontrib><creatorcontrib>Graeber, C W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>QJM : An International Journal of Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goldstein, M R</au><au>Poland, G A</au><au>Graeber, C W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to: Cardiac drugs and outcome in COVID-19</atitle><jtitle>QJM : An International Journal of Medicine</jtitle><addtitle>QJM</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>113</volume><issue>7</issue><spage>525</spage><epage>526</epage><pages>525-526</pages><issn>1460-2725</issn><eissn>1460-2393</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>32289171</pmid><doi>10.1093/qjmed/hcaa128</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1460-2725 |
ispartof | QJM : An International Journal of Medicine, 2020-07, Vol.113 (7), p.525-526 |
issn | 1460-2725 1460-2393 |
language | eng |
recordid | cdi_proquest_miscellaneous_2390145930 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Betacoronavirus Coronavirus Infections COVID-19 Humans Pandemics Pneumonia, Viral SARS-CoV-2 |
title | Response to: Cardiac drugs and outcome in COVID-19 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A16%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to:%20Cardiac%20drugs%20and%20outcome%20in%20COVID-19&rft.jtitle=QJM%20:%20An%20International%20Journal%20of%20Medicine&rft.au=Goldstein,%20M%20R&rft.date=2020-07-01&rft.volume=113&rft.issue=7&rft.spage=525&rft.epage=526&rft.pages=525-526&rft.issn=1460-2725&rft.eissn=1460-2393&rft_id=info:doi/10.1093/qjmed/hcaa128&rft_dat=%3Cproquest_cross%3E2390145930%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2390145930&rft_id=info:pmid/32289171&rft_oup_id=10.1093/qjmed/hcaa128&rfr_iscdi=true |